4//SEC Filing
WILSON TROY EDWARD 4
Accession 0000950170-25-108844
CIK 0001422143other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:05 PM ET
Size
8.5 KB
Accession
0000950170-25-108844
Insider Transaction Report
Form 4
WILSON TROY EDWARD
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-08-12$5.85/sh+36,506$213,578→ 37,474 total - Purchase
Common Stock
2025-08-13$6.64/sh+13,494$89,623→ 50,968 total
Holdings
- 279,194(indirect: By Trust)
Common Stock
- 300,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $5.56 to $5.995. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Includes 409 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]This transaction was executed in multiple trades at prices ranging from $6.485 to $6.735. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001589597
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:05 PM ET
- Size
- 8.5 KB